SGLT2-IN-2
SGLT2-IN-2 (Compound E9) is an inhibitor of SGLT2. SGLT2-IN-2 significantly enhances the inhibition of SGLT2, NHE1, and SOD enzyme activity. SGLT2-IN-2 has protective effect on the glucose-free DMEM-induced injured cardiomyocytes. SGLT2-IN-2 significantly improves cardiac function in TAC-induced HF mice and inhibits cardiomyocyte hypertrophy as well as collagen deposition. SGLT2-IN-2 can ameliorate myocardial tissue damage and enhance mitochondrial autophagy in injured cardiomyocytes, thereby increasing survival rates in HF mice[1].
Product Specifications
UNSPSC
12352005
Target
Autophagy; Na+/H+ Exchanger (NHE) ; SGLT; SOD
Related Pathways
Autophagy; Immunology/Inflammation; Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Purity
99.57
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O[C@@H]1[C@@H](CO)O[C@@H](OC2=CC=C(C3=CN(CC4=CC=CN=C4)N=C3C)C=C2)[C@H](O)[C@H]1O
Molecular Formula
C22H25N3O6
Molecular Weight
427.45
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Striatin 4 (STRN4) (N-term) Rabbit Polyclonal Antibody
CD11c (Dendritic Cell Marker) (ITGAX/2507), 1mg/mL
